Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.
about
The latent transforming growth factor beta binding protein (LTBP) familyInvolvement of transforming growth factor alpha in the regulation of rat ovarian X-linked inhibitor of apoptosis protein expression and follicular growth by follicle-stimulating hormoneTransforming growth factor alpha in epithelial proliferative diseases of the breastGrowth regulation of skin cells by epidermal cell-derived factors: implications for wound healing.Smad signaling in skeletal development and regeneration.Notch signaling activation suppresses v-Src-induced transformation of neural cells by restoring TGF-β-mediated differentiationSequence-specific 1H-NMR assignments and identification of two small antiparallel beta-sheets in the solution structure of recombinant human transforming growth factor alpha.Tumor cell autocrine motility factorInhibitory action of transforming growth factor beta on endothelial cells.Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel.Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogeneModulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.Transforming growth factor-alpha: characterization of the BamHI, RsaI, and TaqI polymorphic regions.Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesionsTransforming growth factor alpha inhibits secretion of gastric acid.Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis.Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth.TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growthLatent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.Transforming growth factor-beta modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-alphaGrowth control in cultured 3T3 fibroblasts. V. Purification of an Mr 13,000 polypeptide responsible for growth inhibitory activity.Cell-mediated co-action of transforming growth factors: incubation of type beta with normal rat kidney cells produces a soluble activity that prolongs the ruffling response to type alphaEnhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.Different roles of TGF-β in the multi-lineage differentiation of stem cells.Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade.Mathematical model of TGF-βsignalling: feedback coupling is consistent with signal switching.Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia.Transforming growth factor-beta is a potent negative regulator of human lymphocytes.Transforming growth factor-beta: possible roles in carcinogenesis.Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.Transforming growth factor alpha: an aromatic side chain at position 38 is essential for biological activity.Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activitiesInduction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblastsDevelopment of a retroviral vector for inducible expression of transforming growth factor beta 1.Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells.Increased secretion of type beta transforming growth factor accompanies viral transformation of cells
P2860
Q24532213-CB3128E7-26B1-4372-AB15-01436D1F03D7Q28564238-07AA3CB3-2EDE-4D50-B25D-373824E55992Q31160943-46103210-E55E-477F-A0A7-4E8F51CA855BQ33560803-8B31154A-3341-4642-BBC0-72DF93B9580BQ33674328-A91E8E72-3DE9-4FC7-9B1A-43986B8EC85CQ33735927-A7B15675-D0AF-4CA9-A8A9-030EE61D27D2Q33839963-7A307343-9FD5-4955-BD90-899CAB596FEAQ34165482-123BCB52-8224-420E-AE37-063689D7C39CQ34337298-DF33F776-2150-4BCE-A288-B343FD2B8C13Q34541763-B3B9B521-F56A-4B7A-98E0-A3E92DCB1CCAQ34568780-768DD2AC-A206-47D0-80CB-E8F43F206C10Q34593947-FA642F3F-329A-42B5-A3A6-45508FFD58A9Q34610078-75D8DD01-4890-4A1C-881F-6E089E810545Q35194627-01A45AFF-FFA1-4AB5-8F06-E78F9DA6080DQ35599307-BC91E485-6D34-42CF-88A4-2808B938B369Q35607475-0F30DF62-A2F1-45B2-BC31-57FF54D5A11DQ35608343-D8358F3F-FDDA-4807-A98F-4C28CB441581Q35610349-9DCC6BEE-2CBF-47E7-AE61-6A636CA65945Q35632615-F1979F08-A83F-4CFC-842A-774706D62DB9Q35818837-199A9675-D5A7-4977-80B4-6F3B539744ECQ35826016-3B38946C-3DE1-42B8-AB85-55BDB95F5CCBQ35861493-78C52D1C-1756-4DA4-8D54-61D07630C4A7Q36213296-1C6211C2-F255-4DC7-8211-A4A14CDE6EB7Q36214427-ED46DE00-8048-4331-837C-EFDB8795BEE4Q36214857-06D8A6FE-CB3C-4BA1-8A57-D79478BC3F9DQ36216679-D43BA591-3C66-4CB7-BEC7-C1E15F7C27F1Q36237924-7F652BD1-1F8A-4316-94BF-E22FDD4E0F23Q36304149-A057329D-C32D-4B4C-99FD-0B504FDE4DB0Q36346393-411064D3-9938-4C4F-918C-A6B428C2AC0DQ36351780-A6195C39-EBA8-4E1E-B0D7-44D56FC3B89FQ36352081-B3961BC7-4D1B-4150-BEA5-D15A49C0E29DQ36401260-654350A6-9738-47EA-87C7-58F2EB155FF2Q36465897-4286A45F-BAC8-4DFE-8390-43D95E519F3FQ36745372-F1D9EB92-BB73-4A03-90FF-274FA3D7759DQ36767000-0A70C7D0-70BE-4B2A-8734-6DF923E84D97Q36785343-540EA899-CB30-42F3-8B16-74598391D30EQ36796387-C10D1816-BAC1-4DB4-8BA1-4D0EA951183CQ36811215-106AA5E9-4F0B-4E32-BFB9-7579D0AB8B6DQ36874189-BBB05A99-87AB-4014-9A70-029B71F425BDQ36885110-0C256305-904A-4B5F-AE61-6BF0CFC06591
P2860
Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sarcoma growth factor from con ...... a transforming growth factors.
@en
Sarcoma growth factor from con ...... a transforming growth factors.
@nl
type
label
Sarcoma growth factor from con ...... a transforming growth factors.
@en
Sarcoma growth factor from con ...... a transforming growth factors.
@nl
prefLabel
Sarcoma growth factor from con ...... a transforming growth factors.
@en
Sarcoma growth factor from con ...... a transforming growth factors.
@nl
P2093
P2860
P356
P1476
Sarcoma growth factor from con ...... a transforming growth factors.
@en
P2093
P2860
P304
P356
10.1073/PNAS.80.20.6264
P407
P577
1983-10-01T00:00:00Z